TCI Wealth Advisors’s Rockwell Medical RMTI Stock Holding History

TCI Wealth Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2	Closed	-$39	–	1805
2023 Q1	$39	Buy	+2	New	+$34	﹤0.01%	2457

Other funds holding RMTI

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TCI Wealth Advisors's RMTI Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Rockwell Medical (RMTI) in Q2 2023, closing a stake of 2 shares — an estimated $39 sold.

TCI Wealth Advisors first reported a position in RMTI in Q1 2023 and held it in 1 quarter. The position peaked at $39 in Q1 2023. 40 funds tracked by Wall St. Rank hold RMTI as of Q2 2023.

TCI Wealth Advisors reported no remaining Rockwell Medical position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 2 Rockwell Medical shares in Q2 2023, an estimated $39.
TCI Wealth Advisors first reported a position in Rockwell Medical in Q1 2023 and held it in 1 quarter.
TCI Wealth Advisors's Rockwell Medical position peaked at $39 in Q1 2023.
40 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.